Congenital Sucrase-Isomaltase Deficiency Archives - Access Market Intelligence

Insights Newsletter

Always Be a Step Ahead

Learn the important healthcare trends that could affect you in advance. Get expert analysis and discover the innovative ideas that are helping businesses overcome today's challenges.

Subscribe to AMI's Insights Newsletter Today.
Login
Contact

Subscribe
Insights Newsletter

Always Be a Step Ahead

Learn the important healthcare trends that could affect you in advance. Get expert analysis and discover the innovative ideas that are helping businesses overcome today's challenges.

Subscribe to AMI's Insights Newsletter Today.
Login

Specialty Drug, Specialty Pharmacy

QOL Medical Selects Optum Frontier Therapies as New Partner for Sucraid®

Posted on April 18, 2022 by John Santilli

18
Apr

QOL Medical Selects Optum Frontier Therapies as New Pharmacy Partner for Sucraid® to support CSID patients nationwide being treated with Sucraid® (sacrosidase) Oral Solution

Continue reading →